Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina
N. Espinola,C. Silvestrini,C. Colaci,D. Sugg,C. Rojas-Roque,J. Coelli and F. Augustovski. Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina. PharmacoEconomics – Open. 2024:10.1007/s41669-024-00508-4.